Qianhong Pharmaceutical (002550.SZ) released results for the first three quarters, with net profit of 215 million yuan to mother, a year-on-year decrease of 43.86%

According to Zhitong Finance App News, Qianhong Pharmaceutical (002550.SZ) released its report for the third quarter of 2026. The company achieved operating income of 1.154 billion yuan in the first three quarters, down 5.01% year on year; net profit attributable to shareholders of listed companies was 215 million yuan, down 43.86% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 200 million yuan, down 26.13% year on year; basic earnings per share were 0.1709 yuan.

During the reporting period, operating income decreased by 5.01% compared to the same period last year. The main reason was that the heparin API business declined compared to the same period last year due to overall demand in overseas markets during the reporting period.